Golimumab Subcutaneous and Insulin glulisine Subcutaneous
Determining the interaction of Golimumab Subcutaneous and Insulin glulisine Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: golimumab
Brand name: Simponi, Simponi SmartJect, Simponi Aria
Synonyms: Golimumab
Generic Name: insulin glulisine
Brand name: Apidra, Apidra OptiClik Cartridge, Apidra SoloStar Pen
Synonyms: Insulin glulisine, Insulin Glulisine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Golimumab Subcutaneous-Insulin human inhaled Inhalation
- Golimumab Subcutaneous-Insulin human regular Injection
- Golimumab Subcutaneous-Insulin inhalation
- Golimumab Subcutaneous-Insulin isophane
- Golimumab Subcutaneous-Insulin isophane and insulin regular
- Golimumab Subcutaneous-Insulin lispro
- Insulin glulisine Subcutaneous-GoLYTELY
- Insulin glulisine Subcutaneous-Gonadorelin
- Insulin glulisine Subcutaneous-Gonadorelin Intravenous, Injection
- Insulin glulisine Subcutaneous-Gonadotropin, Chorionic
- Insulin glulisine Subcutaneous-Gonal-F
- Insulin glulisine Subcutaneous-Gonal-f RFF